In the present work, for the first time we have designed a novel approach for the synthesis of N ‐benzyl‐ N ‐aryl‐5‐amino‐1 H ‐tetrazoles using reduced graphene oxide (rGO) decorated with Cu‐Ni bimetallic nanoparticles (NPs). In situ synthesis of Cu/Ni/rGO nanocomposite was performed by a cost efficient, surfactant‐free and environmentally benign method using Crataegus azarolus var. aronia L. leaf extract as a stabilizing and reducing agent. Phytochemicals present in the extract can be used to reduce Cu 2+ and Ni 2+ ions and GO to Cu NPs, Ni NPs and rGO, respectively. Analyses by means of FT‐IR, UV–Vis, EDS, TEM, FESEM, XRD and elemental mapping confirmed the Cu/Ni/rGO formation and also FT‐IR, NMR, and mass spectroscopy as well as elemental analysis were used to characterize the tetrazoles. The Cu/Ni/rGO nanocomposite showed the superior catalytic activity for the synthesis of N ‐benzyl‐ N ‐aryl‐5‐amino‐1 H ‐tetrazoles within a short reaction time and high yields. Furthermore, this protocol eliminates the need to handle HN 3 .
No takes yet. Share an insight, caveat, or question.
Nasrollahzadeh et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: